P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS

por Maas, Carolien, van Klaveren, David, Durmaz, Mujde, Visser, Otto, Issa, Djamila, Posthuma, Eduardus F.M., Zijlstra, Josée, Chamuleau, Martine, Lugtenburg, Pieternella, José Kersten, Marie, Dinmohamed, Avinash
Publicado 2023

Web-Based Self-Management for Patients With Lymphoma: Assessment of the Reach of Intervention of a Randomized Controlled Trial

por Arts, Lindy P J, Oerlemans, Simone, Posthuma, Eduardus F M, Issa, Djamila E, Oosterveld, Margriet, van der Griend, René, Nijziel, Marten R, van de Poll-Franse, Lonneke V
Publicado 2020

P1523: IMMUNOGENICITY OF THE 13-VALENT PNEUMOCOCCAL CONJUGATED VACCINE FOLLOWED BY THE 23-VALENT POLYSACCHARIDE VACCINE IN CHRONIC LYMPHOCYTIC LEUKEMIA

por Haggenburg, Sabine, Garrido, Hannah Garcia, Kant, Iris, van der Straaten, Hanneke, Boer, Fransien De, Kersting, Sabina, Issa, Djamila, Raa, Doreen Te, Visser, Hein, Kater, Arnon, Goorhuis, Abraham, Heer, Koen De
Publicado 2023

No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study

por Geerdes, Emma E., Durmaz, Müjde, Lugtenburg, Pieternella J., Chamuleau, Martine E. D., Visser, Otto, Issa, Djamila E., Brouwer, Rolf E., Posthuma, Eduardus F. M., Zijlstra, Josée M., Kersten, Marie José, Dinmohamed, Avinash G.
Publicado 2023

P1159: INFERIOR OUTCOME OF FRAIL AND UNFIT PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH ATTENUATED R-CHOP

por Al-Sarayfi, Diana, Brink, Mirian, Chamuleau, Martine E. D., Brouwer, Rolf, van Rijn, Roos, Issa, Djamila, Deenik, Wendy, Huls, Gerwin, Mous, Rogier, Vermaat, Joost S.P., Zijlstra, Josee M., van Meerten, Tom, Nijland, Marcel
Publicado 2023

Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia

por Haggenburg, Sabine, Garcia Garrido, Hannah M., Kant, Iris M. J., Van der Straaten, Hanneke M., De Boer, Fransien, Kersting, Sabina, Issa, Djamila, Te Raa, Doreen, Visser, Hein P. J., Kater, Arnon P., Goorhuis, Abraham, De Heer, Koen
Publicado 2023

Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989–2018

por Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F. M., Brouwer, Rolf E., Issa, Djamila E., de Jong, Daphne, Lam, King H., Blijlevens, Nicole M. A., Zijlstra, Josée M., Chamuleau, Martine E. D., Lugtenburg, Pieternella J., Kersten, Marie José, Dinmohamed, Avinash G.
Publicado 2022

Web-Based Return of Individual Patient-Reported Outcome Results Among Patients With Lymphoma: Randomized Controlled Trial

por Oerlemans, Simone, Arts, Lindy Paulina Johanna, Kieffer, Jacobien M, Prins, Judith, Hoogendoorn, Mels, van der Poel, Marjolein, Koster, Ad, Lensen, Chantal, Stevens, Wendy Bernadina Catharina, Issa, Djamila, Pruijt, Johannes F M, Oosterveld, Margriet, van der Griend, René, Nijziel, Marten, Tick, Lidwine, Posthuma, Eduardus F M, van de Poll-Franse, Lonneke V
Publicado 2021

R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

por Al-Sarayfi, Diana, Meeuwes, Frederik O., Durmaz, Müjde, Issa, Djamila E., Brouwer, Rolf E., Beeker, Aart, van Rhenen, Anna, Mutsaers, Pim G. N. J., Böhmer, Lara H., van der Poel, Marjolein W. M., te Boome, Liane, van Meerten, Tom, Chamuleau, Martine E. D., Zijlstra, Josée M., Brink, Mirian, Nijland, Marcel
Publicado 2022

P1128: EVALUATION OF STANDARD OF CARE IN SECOND-LINE FOR PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE PRE-CAR-T ERA: A DUTCH POPULATION-BASED STUDY

por Pennings, Elise R.A., Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F.M., Issa, Djamila E., Chamuleau, Martine E.D., Spanjaart, Anne M., van Meerten, Tom, Mutsaers, Pim G.N.J., Jak, Margot, van Dorp, Suzanne, Vermaat, Joost S.P., van der Poel, Marjolein W.M., Kuipers, Maria T., Thielen, Frederick W., Uyl-de Groot, Carin A., Lugtenburg, Pieternella J., José Kersten, Marie, Dinmohamed, Avinash G.
Publicado 2023

P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE...

por Groen, Kaz, Stege, Claudia, Nasserinejad, Kazem, de Heer, Koen, van Kampen, Roel J.W., Leys, Rineke B.L., Thielen, Noortje, Westerman, Matthijs, Wu, Ka-Lung, Ludwig, Inge, Issa, Djamila E., Velders, Gerjo A., Vekemans, Marie-Christiane, van de Donk, Niels W.C.J., Timmers, Gert-Jan, de Boer, Fransien, Tick, Lidwine W., van der Spek, Ellen, de Waal, Esther G.M., Sohne, Maaike, Sonneveld, Pieter, Nijhof, Inger S., Klein, Saskia K., Levin, Mark-David, Ypma, Paula F., Zweegman, Sonja
Publicado 2023

Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial

por Groen, Kaz, Stege, Claudia A.M., Nasserinejad, Kazem, de Heer, Koen, van Kampen, Roel J.W., Leys, Rineke B.L., Thielen, Noortje, Westerman, Matthijs, Wu, Ka-Lung, Ludwig, Inge, Issa, Djamila E., Velders, Gerjo A., Vekemans, Marie-Christiane, Timmers, Gert-Jan, de Boer, Fransien, Tick, Lidwine W., Verbrugge, Annelies, Buitenhuis, Danny, Cunha, Sonia M., van der Spek, Ellen, de Waal, Esther G.M., Sohne, Maaike, Sonneveld, Pieter, Nijhof, Inger S., Klein, Saskia K., van de Donk, Niels W.C.J., Levin, Mark-David, Ypma, Paula F., Zweegman, Sonja
Publicado 2023